American Journal of Cardiology
Volume 99, Issue 9 , Pages 1208-1211, 1 May 2007

Prognostic Impact of Acute Beta-Blocker Therapy on Top of Aspirin and Angiotensin-Converting Enzyme Inhibitor Therapy in Consecutive Patients With ST-Elevation Acute Myocardial Infarction

  • Harm Wienbergen, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Tel: 01149-621-503-4000; fax: 01149-621-503-4044.
  • ,
  • Uwe Zeymer, MD
  • ,
  • Anselm Kai Gitt, MD
  • ,
  • Claus Juenger, MD, MPH
  • ,
  • Rudolf Schiele, MD
  • ,
  • Tobias Heer, MD
  • ,
  • Frank Towae, MD
  • ,
  • Jochen Senges, MD
  • ,
  • MITRA PLUS Study Group

      Affiliations

    • The MITRA PLUS study was supported by the Landesversicherungsanstalt, Rheinland Pfalz, Germany; the Ministerium für Arbeit, Soziales und Gesundheit, Rheinland-Pfalz, Germany; MSD Sharp & Dohme, Haar, Germany; Bristol-Myers Squibb, München, Germany; Aventis Pharma, Bad Soden, Germany; AstraZeneca, Wedel, Germany; Pfizer, Karlsruhe, Germany; and Abbott, Ludwigshafen, Germany.

Herzzentrum Ludwigshafen, Institut für Herzinfarktforschung, Ludwigshafen, Germany.

Received 13 September 2006; received in revised form 7 December 2006; accepted 7 December 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9149(07)00147-6

doi:10.1016/j.amjcard.2006.12.036

American Journal of Cardiology
Volume 99, Issue 9 , Pages 1208-1211, 1 May 2007